Worth reading
69In focus
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
683000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise status of the 16th stock acquisition rights issued through third-party allotment (with Exercise Price Adjustment Clause)
Who receives how much
Shares delivered during the month: 683,000 shares (683,000 new shares and 0 transferred treasury shares)
EVO FUND (the allottee at the time of issuance on 1 August 2025)
The lower thin line represents the existing number of shares to which these shares will be added.
発行済株式総数
Exercise ratio subject to exercise restrictions: 10.0% (683,000 shares / 6,837,200 shares)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Subject to an exercise price adjustment clause. The exercise price during the month ranged from ¥416 to ¥511. The adjustment floor was Not disclosed
Number of Stock Acquisition Rights
Total issued: 17,000 stock acquisition rights. Exercised during the month: 6,830; unexercised at the end of the previous month: 11,980; unexercised at month-end: 5,150
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations
Most recent equity financing
Timing 1 August 2025 / Type Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment provisions) / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise status of the 16th stock acquisition rights issued through third-party allotment (with Exercise Price Adjustment Clause) |
| Number of shares to be issued or disposed of | Shares delivered during the month: 683,000 shares (683,000 new shares and 0 transferred treasury shares) |
| Intended allottee | EVO FUND (the allottee at the time of issuance on 1 August 2025) |
| Dilution Rate | Exercise ratio subject to exercise restrictions: 10.0% (683,000 shares / 6,837,200 shares) |
| Total number of issued shares | As of 31 March 2026: 7,395,200 shares (including 183 treasury shares) → Not disclosed |
| Exercise price | Subject to an exercise price adjustment clause. The exercise price during the month ranged from ¥416 to ¥511. The adjustment floor was Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 17,000 stock acquisition rights. Exercised during the month: 6,830; unexercised at the end of the previous month: 11,980; unexercised at month-end: 5,150 |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations |
| Most recent equity financing | Timing 1 August 2025 / Type Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment provisions) / Amount Not disclosed |
Items this document does not state (19)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status of the stock acquisition rights.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.